PL2218452T3 - Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry - Google Patents

Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry

Info

Publication number: PL2218452T3
Authority: PL; Poland
Prior art keywords: citrulline; asparagine; arginine; pyrrolidone; compound
Prior art date: 2007-05-22

Application number

PL10165250T

Other languages

English (en)

Inventor

Johannes Voegel

Emmanuelle At

Carine Rosignoli

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-22

Filing date

2008-05-22

Publication date

2016-04-29

2008-05-22 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2016-04-29 Publication of PL2218452T3 publication Critical patent/PL2218452T3/pl

Links

ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 title 1
239000004475 Arginine Substances 0.000 title 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 title 1
206010012438 Dermatitis atopic Diseases 0.000 title 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 title 1
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 title 1
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 title 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
229960003121 arginine Drugs 0.000 title 1
235000009697 arginine Nutrition 0.000 title 1
235000009582 asparagine Nutrition 0.000 title 1
229960001230 asparagine Drugs 0.000 title 1
201000008937 atopic dermatitis Diseases 0.000 title 1
235000013477 citrulline Nutrition 0.000 title 1
229960002173 citrulline Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

PL10165250T 2007-05-22 2008-05-22 Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry PL2218452T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR0755186A FR2916351B1 (fr)	2007-05-22	2007-05-22	Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
US92471207P	2007-05-29	2007-05-29
EP10165250.1A EP2218452B1 (en)	2007-05-22	2008-05-22	Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
EP08759934.6A EP2164482B1 (en)	2007-05-22	2008-05-22	Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis

Publications (1)

Publication Number	Publication Date
PL2218452T3 true PL2218452T3 (pl)	2016-04-29

Family

ID=38606551

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10165250T PL2218452T3 (pl)	2007-05-22	2008-05-22	Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry
PL08759934T PL2164482T3 (pl)	2007-05-22	2008-05-22	Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL08759934T PL2164482T3 (pl)	2007-05-22	2008-05-22	Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry

Country Status (15)

Country	Link
US (1)	US8795705B2 (pl)
EP (2)	EP2164482B1 (pl)
JP (2)	JP2010527970A (pl)
KR (1)	KR20100017202A (pl)
CN (1)	CN101686957A (pl)
BR (1)	BRPI0810323A2 (pl)
CA (1)	CA2687324A1 (pl)
ES (2)	ES2554776T3 (pl)
FR (1)	FR2916351B1 (pl)
HU (2)	HUE025824T2 (pl)
MX (1)	MX2009012472A (pl)
PL (2)	PL2218452T3 (pl)
PT (2)	PT2218452E (pl)
RU (1)	RU2476214C2 (pl)
WO (1)	WO2008142147A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5689026B2 (ja) *	2010-06-17	2015-03-25	株式会社資生堂	水中油型乳化皮膚化粧料
KR101066859B1 (ko) *	2010-12-10	2011-09-26	전명자	패드 및 이를 포함하는 깔창
JP6009147B2 (ja) *	2011-03-15	2016-10-19	株式会社資生堂	ブレオマイシン水解酵素産生促進剤
RU2538084C1 (ru) *	2013-07-25	2015-01-10	Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздрава России)	Средство для лечения и профилактики атопического дерматита
KR101732428B1 (ko)	2015-06-25	2017-05-24	이정재	탄성 리포좀 조성물 및 이를 포함하는 화장료 조성물
KR102396603B1 (ko)	2015-09-16	2022-05-11	원광대학교산학협력단	시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물
US9909427B2 (en)	2015-12-22	2018-03-06	General Electric Company	Turbine airfoil with trailing edge cooling circuit
CN115671098A (zh) *	2016-06-17	2023-02-03	药物递送解决方案私人有限责任公司	用于治疗尿毒性瘙痒症的制剂
CN112137995A (zh)	2019-06-28	2020-12-29	默克专利股份有限公司	增加皮肤细胞中钙的细胞利用率的方法和混合物
CN112569162B (zh) *	2019-09-27	2024-04-12	默克专利股份有限公司	麦冬提取物、氨基酸、氨基酸衍生物和乳酸钙水合物的协同作用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61215308A (ja)	1985-03-20	1986-09-25	Shiseido Co Ltd	皮膚外用剤
JPS61215307A (ja)	1985-03-20	1986-09-25	Shiseido Co Ltd	皮膚外用剤
JPH0729911B2 (ja)	1986-05-15	1995-04-05	株式会社資生堂	皮膚外用剤
US4837019A (en) *	1986-08-11	1989-06-06	Charles Of The Ritz Group Ltd.	Skin treatment composition and method for treating burned skin
DE4341000A1 (de) *	1993-12-02	1995-06-08	Beiersdorf Ag	Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
JPH0820525A (ja)	1994-07-06	1996-01-23	Nendo Kagaku Kenkyusho:Kk	ボディシャンプ
ES2132855T3 (es)	1995-09-07	1999-08-16	Oreal	Extracto de iridaceas y composiciones que lo contienen.
EP0761204B1 (fr)	1995-09-07	1998-04-15	L'oreal	Utilisation d'un extrait d'une bactérie filamenteuse non photosynthétique et composition le contenant
JP3525233B2 (ja)	1995-09-20	2004-05-10	味の素株式会社	化粧料
FR2768622B1 (fr)	1997-09-22	1999-11-26	Oreal	Extrait de rosacees en tant qu'antagoniste de bradykinine
FR2778562B1 (fr) *	1998-05-14	2000-08-04	Sephra	Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
DE19831798A1 (de) *	1998-07-15	2000-01-27	Mandorlo Investment Gmbh Luxem	Mittel zur Pflege und/oder Behandlung von Haut und Gewebe
JP2002053428A (ja)	2000-08-12	2002-02-19	Tadashi Fukiya	皮膚外用剤
JP4681132B2 (ja)	2001-01-29	2011-05-11	味の素株式会社	一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
DE10111049A1 (de) *	2001-03-06	2002-09-12	Beiersdorf Ag	Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
JP4851046B2 (ja)	2002-06-19	2012-01-11	味の素株式会社	細胞への塩基性アミノ酸取り込み促進剤および医薬組成物
JP2004168763A (ja) *	2002-10-30	2004-06-17	Dsr Corp	皮膚化粧料
US20060063827A1 (en) *	2004-09-23	2006-03-23	Yu Ruey J	Systemic administration of therapeutic amino acids and N-acetylamino acids
JPWO2005077349A1 (ja)	2004-02-17	2007-10-18	大塚製薬株式会社	ヒトβディフェンシン産生促進剤

2007
- 2007-05-22 FR FR0755186A patent/FR2916351B1/fr not_active Expired - Fee Related
2008
- 2008-05-22 PL PL10165250T patent/PL2218452T3/pl unknown
- 2008-05-22 PT PT101652501T patent/PT2218452E/pt unknown
- 2008-05-22 PL PL08759934T patent/PL2164482T3/pl unknown
- 2008-05-22 HU HUE08759934A patent/HUE025824T2/en unknown
- 2008-05-22 RU RU2009147465/15A patent/RU2476214C2/ru active
- 2008-05-22 BR BRPI0810323-2A2A patent/BRPI0810323A2/pt not_active Application Discontinuation
- 2008-05-22 US US12/601,113 patent/US8795705B2/en active Active
- 2008-05-22 WO PCT/EP2008/056333 patent/WO2008142147A1/en not_active Ceased
- 2008-05-22 EP EP08759934.6A patent/EP2164482B1/en active Active
- 2008-05-22 HU HUE10165250A patent/HUE026388T2/en unknown
- 2008-05-22 CA CA002687324A patent/CA2687324A1/en not_active Abandoned
- 2008-05-22 PT PT87599346T patent/PT2164482E/pt unknown
- 2008-05-22 JP JP2010508859A patent/JP2010527970A/ja active Pending
- 2008-05-22 CN CN200880016754A patent/CN101686957A/zh active Pending
- 2008-05-22 KR KR1020097024242A patent/KR20100017202A/ko not_active Ceased
- 2008-05-22 ES ES08759934.6T patent/ES2554776T3/es active Active
- 2008-05-22 EP EP10165250.1A patent/EP2218452B1/en active Active
- 2008-05-22 ES ES10165250.1T patent/ES2554834T3/es active Active
- 2008-05-22 MX MX2009012472A patent/MX2009012472A/es active IP Right Grant
2014
- 2014-01-10 JP JP2014003184A patent/JP2014065742A/ja active Pending

Also Published As

Publication number	Publication date
CN101686957A (zh)	2010-03-31
ES2554776T3 (es)	2015-12-23
AU2008252925A1 (en)	2008-11-27
BRPI0810323A2 (pt)	2014-10-14
KR20100017202A (ko)	2010-02-16
EP2164482A1 (en)	2010-03-24
CA2687324A1 (en)	2008-11-27
US8795705B2 (en)	2014-08-05
PT2164482E (pt)	2016-02-03
HUE026388T2 (en)	2016-06-28
RU2476214C2 (ru)	2013-02-27
EP2218452A1 (en)	2010-08-18
PL2164482T3 (pl)	2016-05-31
HUE025824T2 (en)	2016-05-30
ES2554834T3 (es)	2015-12-23
EP2164482B1 (en)	2015-10-07
PT2218452E (pt)	2016-01-27
FR2916351A1 (fr)	2008-11-28
US20100291002A1 (en)	2010-11-18
JP2010527970A (ja)	2010-08-19
FR2916351B1 (fr)	2012-12-07
RU2009147465A (ru)	2011-06-27
EP2218452B1 (en)	2015-09-30
JP2014065742A (ja)	2014-04-17
MX2009012472A (es)	2009-12-01
WO2008142147A1 (en)	2008-11-27

Publication	Publication Date	Title
PL2164482T3 (pl)	2016-05-31	Kombinacja zawierająca kwas pirolidono-5-karboksylowy i przynajmniej jeden związek spośród cytruliny, argininy i asparaginy oraz jej zastosowanie do leczenia atopowego zapalenia skóry
IL205318A0 (en)	2010-12-30	Compositions comprising electrochemically altered aqueous fluids and uses thereof for treating inflammation
IL215592A (en)	2017-02-28	Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
IL204621A0 (en)	2010-11-30	Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
GB2485291B (en)	2013-03-27	Cannabidiol for use in the treatment of generalised and/or partial seizures
IL249141B (en)	2019-03-31	Preparations for the treatment of parasites containing a large number of active factors, their methods and uses
WO2012100097A3 (en)	2012-10-26	Topical minocycline compositions and methods of using the same
PL2894165T3 (pl)	2023-04-17	Sposoby i kompozycje do leczenia zaburzeń układu dopełniacza
IL216723A0 (en)	2012-03-01	1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer
SG10201401415QA (en)	2014-08-28	Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
IL220129A (en)	2017-06-29	History of benzamide, preparations containing them and their use in the treatment of cancer
IL212836A0 (en)	2011-07-31	Azaquinolinone derivatives, compositions comprising the same and uses thereof
IL220283A0 (en)	2012-07-31	4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
EP2337535A4 (en)	2012-01-18	SYSTEMS, DEVICES AND METHODS FOR THE TREATMENT OF ACOUPHEN
IL219325A0 (en)	2012-06-28	Gadd45beta targeting compounds, compositons comprising the same and uses thereof
IL226270A0 (en)	2013-07-31	History of hydroxamic acid, preparations containing them and their uses
IL212278A0 (en)	2011-06-30	Morpholinopurine derivatives, compositions comprising the same and uses thereof
IL213043A0 (en)	2011-07-31	Lantibiotic carboxyamide derivatives, compositions comprising the same and uses thereof
IL212909A0 (en)	2011-07-31	Anti - wrinkle agents and compositons comprising the same
IL223405B (en)	2018-11-29	Phosphoplatins, preparations containing them and their uses
PL2235013T3 (pl)	2012-11-30	Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach
IL207639A0 (en)	2010-12-30	Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
EP2241382A4 (en)	2013-07-24	ROLLING MILL AND TANDEM ROLLER HAVING THE SAME
IL216828A0 (en)	2012-02-29	Styryl-triazine derivatives, compositions comprising the same and uses thereof
IL208168A0 (en)	2010-12-30	Tetrahydroisoquinoline derivatives, compositions comprising the same and use thereof